AT1-receptor blockers: differences that matter
- 29 July 2002
- journal article
- review article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 16 (S3) , S9-S16
- https://doi.org/10.1038/sj.jhh.1001434
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clinical comparative trials of angiotensin II type 1 (AT1)-receptor blockers.Blood Pressure, 2001
- How Can the Differences Among AT1-Receptor Antagonists Be Explained?Cell Biochemistry and Biophysics, 2001
- In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartanAmerican Journal of Hypertension, 2000
- Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic ConceptBlood Pressure, 2000
- Mechanistic Differences of Various AT 1 -Receptor Blockers in Isolated Vessels of Different OriginHypertension, 1999
- Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptorEuropean Journal of Pharmacology, 1997
- Opposite Effects of Angiotensin AT 1 and AT 2 Receptor Antagonists on Recovery of Mechanical Function After Ischemia-Reperfusion in Isolated Working Rat HeartsCirculation, 1996
- Role of Type 1 and Type 2 Angiotensin Receptors in Angiotensin II–Induced Cardiomyocyte HypertrophyHypertension, 1996
- Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistBiochemical Pharmacology, 1993
- Angiotensin II Receptors and Functional CorrelatesAmerican Journal of Hypertension, 1992